GD
59
3
TSCO
62
3
VFC
38
-9
MET
54
4
D
32
-5
WFC
58
3
WAT
37
-4
HPE
51
-2
CI
46
-12
NVDA
66
-2
NOV
45
12
APD
55
-4
KSS
38
2
HBI
37
3
VRTX
69
-2
AZO
50
7
CVS
49
12
SIG
47
4
AON
50
3
SJM
36
2
GD
59
3
TSCO
62
3
VFC
38
-9
MET
54
4
D
32
-5
WFC
58
3
WAT
37
-4
HPE
51
-2
CI
46
-12
NVDA
66
-2
NOV
45
12
APD
55
-4
KSS
38
2
HBI
37
3
VRTX
69
-2
AZO
50
7
CVS
49
12
SIG
47
4
AON
50
3
SJM
36
2
Financhill
Back

Voyager Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
36

VYGR
Voyager Therapeutics

Last Price:
8.23
Seasonality Move:
-4.58%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.26
Seasonality Move:
3.65%
Sell
36
Voyager Therapeutics (VYGR) is a Sell

Is Voyager Therapeutics a Buy, Sell or Hold?

  • The current Voyager Therapeutics [VYGR] share price is $8.26. The Score for VYGR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • VYGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VYGR Stock Price Chart

What is Voyager Therapeutics's stock price today?

  • The Voyager Therapeutics share price today is $8.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VYGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 45.55 Sell
Chaikin Money Flow: -178339 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.2 - 8.68) Sell
Bollinger Bands (100): (7.7 - 9.22) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

VYGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.57 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.33 Sell
200-day SMA: 8.07 Buy
8-day EMA: 8.52 Sell
20-day EMA: 8.48 Sell
50-day EMA: 8.46 Sell
200-day EMA: 8.35 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Voyager Therapeutics Earnings Growth & VYGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.13 per share, a decrease this year of $3.04 per share, and a decrease next year of $0.08 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Voyager Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):